Showing 131-135 of 152 real-world data & outcomes research:
New Project Puts Standardized Outcomes Measures For Depression Into Real-World Use, From Registries To The Clinic

New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic  OM1 partners with AHRQ, ABFM, APA and others to implement  BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]

BHE & OM1 Partner to Deliver Rheumatology Registries Through IHD

Research-Grade, Analytic-Ready Rheumatology Data at Your Fingertips through the IHD Platform What would you do with rapid access to analytics and insights from hundreds of thousands of rheumatology patients? Bringing together the largest linked, longitudinal rheumatology condition registries with the industry-leading Instant Health Data (IHD) platform, OM1 and BHE join forces to deliver a powerful[…]

OM1 Expands Rheumatology Conditions With Specialized Data For Licensing And Advanced Analytics

BOSTON, April 30, 2019 — OM1, a leading health outcomes, data and technology company today announced that its rheumatology registries, which track hundreds of thousands of patients longitudinally throughout the United States, are now available for direct licensing as well as studies and advanced analytics. The registries include: Rheumatoid Arthritis Systemic Lupus Erythematosus Sjögrens Giant[…]

Applying AI for personalized treatment decisions and lowering costs in orthopedics

Becker’s Spine Review | Written by Richard Gliklich, MD, CEO, OM1 | November 26, 2018 In healthcare, results really matter Understanding why certain treatments and procedures work better on some patients and not so well on others is the key to delivering more personalized care and ultimately achieving better results for all stakeholders in the care process.[…]